Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
about
Relation of serum serotonin levels to bone density and structural parameters in womenAnalgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndromeProtease inhibition as new therapeutic strategy for GI diseasesRegulation of the serotonin transporter in the pathogenesis of irritable bowel syndromeIdentification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes.Review article: new receptor targets for medical therapy in irritable bowel syndromeSerotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndromeSerotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotoninAcupuncture for visceral pain: neural substrates and potential mechanisms.Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment.Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human ColonDifferences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects.JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsRotavirus and Serotonin Cross-Talk in DiarrhoeaOlanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase.The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.The effect and mechanism of electroacupuncture at LI11 and ST37 on constipation in a rat model.Serotonin in the gastrointestinal tract.Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats.Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit.Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Epithelial expression and function of trypsin-3 in irritable bowel syndrome.PAR-2-mediated control of barrier function and motility differs between early and late phases of postinfectious gut dysfunction in the rat.Protease-activated receptors as therapeutic targets in visceral pain.Effect of progesterone on colonic motility and fecal output in mice with diarrhea.Visceral hypersensitivity in female but not in male serotonin transporter knockout rats.Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells.Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.Effects of dietary L-tryptophan supplementation on intestinal response to chronic unpredictable stress in broilers.Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity.Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease.Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
P2860
Q24620295-80CED1FE-9822-4446-A8A9-5E366B0CFCB7Q24631963-2B6957C3-9D68-4BD0-9DAD-FFA1A69D23A0Q26747722-B13A4C8D-6F39-4B4C-910B-5F694D2FE0B3Q28072085-2E7AC154-3F4B-48B2-AFFA-57C3F2792C47Q33795126-D98D9633-8050-44FA-BF01-C75217B5F409Q33959307-F5759E6A-3164-4507-9D9B-3D4405EB0111Q33987389-1D4F18F1-1691-45D8-9430-AE59060C9D8DQ34028451-7AC12D43-A54E-4A72-9372-B992756F910DQ34303024-293DFF6F-D50E-4B50-AEEA-BB26A11DD493Q34425563-10C7E657-A9AB-4331-AF51-FB0698B970ECQ34790812-42BD8FF1-AEF9-463A-9438-8645B0D0A347Q34966570-D776B2EB-D66B-442F-B983-AD216B7056B0Q34992347-22A5A0D2-8E49-4F7B-844E-D4B5F4CE8443Q35120008-1B3CADA6-F5E3-43C4-B4A9-84849FD85AF3Q35834548-17E0C20B-3165-4856-B608-34A415CA7877Q35848620-389F9BDA-9B14-479D-AE21-0FA447CCF6EFQ36036768-A37D7392-A058-4BED-A54F-FDDC4E209CE3Q36086012-3D00D6AD-5091-45C0-B9FB-5C705EF0B7BFQ36772513-9AC63C6D-E9D4-459B-A498-25F5BFD7D438Q36998938-E65690CF-4C79-4533-8F45-2FBEE9C33F75Q37085603-4884D913-2F3B-4357-B2D0-B1B8F48C91C7Q37223378-F4795489-6343-4727-9A18-16EC3014FA7CQ37370846-91174636-6B37-4CC8-9E95-9637E8D46FEDQ37716041-58E8D8F3-FFCD-4149-9219-38E372703843Q38104610-8F1450F7-8933-4E57-9B1A-64BAE10E37CAQ38193901-C20C279F-FBD6-4BC4-A897-02BB62E5517AQ38275041-F9130E87-750B-47F8-9A40-431178CA7AF8Q39302488-F43D9A0E-4AF8-45E1-B448-5D6E2DF88567Q42517913-70C9495D-F609-4894-BAFD-7D77A4A57DC2Q42849011-DA28626D-02FD-4380-A449-09496D5E067BQ43339666-3A26F657-DB7F-4953-9788-36377423C20DQ44883653-1C8A3C0B-9789-42CD-8F06-842AF8D7A67AQ46258357-C54E48A0-D6F5-4305-BB6E-EADD4846F421Q49940453-B209D607-F784-4F15-AF7C-F3F72CEC2BC9Q50584030-136FD03E-3ECF-4696-BB74-5BC9B4EDD572Q50952188-7EEC1279-ABE2-4472-9551-DE24046B392CQ51011473-70F06A3D-C411-43C8-885D-ABA034222229Q53839188-C00C8A5C-FAFE-4887-9A26-707D4B553B5BQ54228925-5023295D-9B04-42C9-A37B-683A3EB3190DQ54318133-3AF4C195-5591-41D1-82FD-B6D36A44E7B1
P2860
Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@en
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@nl
type
label
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@en
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@nl
prefLabel
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@en
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@nl
P2093
P1476
Trypsinogen IV, serotonin tran ...... table bowel syndrome patients.
@en
P2093
A P M Kerckhoffs
J J M Ter Linde
L M A Akkermans
P304
P356
10.1111/J.1365-2982.2008.01100.X
P577
2008-03-07T00:00:00Z